Jaime Dickerson
About Jaime Dickerson
Jaime Dickerson serves as the Vice President of Strategic Clinical Evidence at Sight Sciences, Inc. He has extensive experience in clinical affairs, having held various leadership roles in companies such as Smith & Nephew and Alcon, with a focus on ophthalmology and wound healing.
Work at Sight Sciences
Jaime Dickerson currently serves as the Vice President of Strategic Clinical Evidence at Sight Sciences, Inc., a position held since 2020. In this role, he focuses on developing strategic clinical evidence to support the company's initiatives. Prior to this, he was the Senior Director of Clinical Affairs at Sight Sciences from 2019 to 2020, where he contributed to the clinical strategy and operations.
Previous Experience at Smith & Nephew
Jaime Dickerson worked at Smith & Nephew from 2012 to 2017. He held the position of Vice President of Global Medical & Clinical Affairs and Vice President of Global Clinical Operations during his tenure, which lasted three years in the Dallas/Fort Worth Area. Prior to this, he served as Senior Director of Medical & Clinical Affairs from 2012 to 2014.
Experience at Alcon, A Novartis Division
Jaime Dickerson's career at Alcon, a division of Novartis, spanned from 1984 to 2019. He held various roles, including Sr. Global Brand Medical Affairs Lead from 2017 to 2019 and various positions in Clinical Development for 26 years. His extensive experience in this organization contributed to his expertise in ophthalmology.
Education and Expertise
Jaime Dickerson earned a PhD in Biochemistry from the UNT Health Science Center, studying from 1988 to 1994. His educational background supports his extensive expertise in ophthalmology and wound healing. He has developed skills in engaging with Key Opinion Leaders (KOLs) and investigators, which enhances collaboration in clinical settings.
Communication Skills
Jaime Dickerson demonstrates proficiency in both oral and written communication. His skills facilitate effective presentations and interactions within the pharmaceutical, biologic, and device industries. This ability enhances his effectiveness in his current role and throughout his career.